Abstract
Environmental factors are playing an increasing etiologic role in the development of disease [1]. This includes both non-malignant and malignant illnesses. The occupational diseases do not differ biologically from other, non-occupationally-induced diseases, but are unique in their relation to the occupational-environmental conditions under which they have been induced. Recognition of risk to a certain population and the identification of causative environmental factors is, therefore, of profound importance; in fact, this forms the basis upon which the success of controlling environmental health hazards ultimately will depend.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
I. J. Selikoff, in: Scientific Basis for Control of Environmental Health Hazards, in: Public Health and Preventive Medicine (Maxcy-Rosenau and John M. Last, eds.), 11th edition, pp. 529–548, Appleton-Century-Crofts (1980).
I. J. Selikoff, E. C. Hammond, and H. Seidman, Latency of asbestos disease among insulation workers in the United States and Canada, Cancer, 46: 2736–2740 (1980).
I.J. Selikoff and E. C. Hammond, Asbestos-associated disease in the United States Shipyards, CA (A Journal for Clinicians), 28: 87–99 (1978).
Immunologic Considerations in Toxicology (Raghubir P. Sharma, ed.), CRC Press, Inc., Boca Raton, Florida (ISBN 0-8493-5271-1) (1981).
J. H. Dean, M. I. Luster, G. A. Boorman, K. Chae, L. D. Lauer, R. W. Luebke, L. D. Lawson, and R. E. Wilson, Assessment of Immunotoxicity Induced by Environmental Chemicals 2,3,7,8-Tetra- chlorodibenzo-p-dioxin, Diethylstilbestrol and Benzo(a)pyrene in ’Proceedings of the First International Conference on Immunopharmacology’, July, 1980, Brighton, England, Adv. Immunopharmacology (J. Hadden, L. Chedid, P. Kullen, and F. Sprefacio, eds. ), Pergamon Press (1981).
R. A. Malmgren, B. E. Bennison, T. W. McKinley, Jr., Reduced antibody titers in mice treated with carcinogenic and cancer chemotherpeutic agents, Proc. Soc. Exp. Biol. Med., 79: 484–488 (1952).
R. T. Phren, Function of depressed immunologic reactivity during carcinogenesis, J. Nat. Cancer Inst., 31: 791–805 (1963).
C. W. Gherke, K. C. Kuo, T. P. Waalkes, and E. Borek, Patterns of urinary excretion of modified nucleosides, Cancer Res., 39: 1150–1153 (1978).
J. Speer, C. W. Gehrke, K. C. Kuo, T. P. Waalkes, and E. Borek, tRNA breakdown products as markers for cancer, Cancer, 44: 2120–2123 (1979).
E. Borek, B. S. Baliga, C. W. Gehrk, C. W. Kuo, S. Belman, W. Troll, and T. P. Waalkes, High turnover rate of transfer RNA in tumor tissue, Cancer Res., 37: 3362–3366 (1977).
K. Kay, Polybrominated biphenyls (PBB) environmental contamination in Michigan, 1973–1976, Environ. Rev., 13: 74–93 (1977).
T. F. Jackson and F. L. Halbert, Toxic syndrome associated with feeding of polybrominated biphenyl-contaminated protein concentrate to dairy cattle, J. Amer. Vet. Med. Assoc., 165: 437–439 (1974).
M. W. Wastell, D. L. Moody, and J. F. Plog, Jr., Effects of polybrominated biphenyl on milk production, reproduction, and health problems in Holstein Cows, Env. Hlth. Persp-ct., 23: 99–103 (1978).
P. D. Moorhead, Pathology of experimentally-induced polybrominated biphenyl toxicosis in pregnant heifers, J. Amer. Vet. Med. Assoc., 170: 307–313 (1977).
M. I. Luster, R. E. Faith, and J. A. Moore, Effects of PBB on immune response in rodents, Env. Hlth. Perspect., 23: 227–232 (1978).
M. S. Wolff, H. A. Anderson, and I. J. Selikoff, Human tissue burdens of halogenated aromatic chemicals in Michigan, J. Amer. Med. Assoc., 247: 2112–2116 (1982).
H. A. Anderson, M. S. Wolff, R. Lilis, E. C. Holstein, J. A. Valciukas, K. E. Anderson, M. Petrocci, L. Sarkozi, and I. J. Selikoff, Symptoms and clinical abnormalities following ingestion of polybrominated biphenyl-contaminated food products, Ann. N.Y. Acad. Sci., 320: 684–702 (1979).
M. S. Wolff, H. A. Anderson, K. D. Rosenman, and I. J. Selikoff, Equilibrium of polybrominated biphenyl (PBB) residues in serum and fat of Michigan residents, Bull. Env. Contam. Toxicol., 21: 775–781 (1979).
J. G. Bekesi, J. F. Holland, H. A. Anderson, A. S. Fischbein, W. Rom, M. S. Wolff, and I. J. Selikoff, Lymphocyte function of Michigan dairy farmers exposed to polybrominated biphenyls, Science, 199: 1207–1209 (1978).
J. Roboz, R. K. Suzuki, J. G. Bekesi, J. F. Holland, and I. J. Selikoff, Mass spectrometric identification and quantification of polybrominated biphenyls in blood compartments of Michigan chemical workers, J. Env. Pathol. Toxicol., 3: 363–378 (1979).
J. G. Bekesi, H. Anderson, J. Roboz, and I. J. Selikoff, Investigation of the immunobiological effects of polybrominated biphenyls in Michigan farmers, in: “Biological Relevance of Immune Suppression as induced by Genetic Therapeutic and Environmental Factors” (J. Dean and M. Padarathsingh, eds.), Van Nostrand Reinhold Company, pp. 119–135, New York (1981).
I. J. Selikoff, Occupational respiratory disease: Asbestos- associated disease, in: Public Health and Preventive Medicine, (Maxcy-Rosenau and John M. Last, eds.), 11th edition, pp. 568–598 and 641–644, Appleton-Century-Crofts(1980).
R. Doll, Mortality from lung cancer in asbestos workers, Brit. J. Ind. Med., 12: 81–86 (1955).
I.J. Selikoff, Lung cancer and mesothelioma during prospective surveillance of 1249 asbestos insulation workers, 1963–1974; Ann. N.Y. Acad. Sci., 271: 488–456 (1976).
I.J. Selikoff, H. Seidman, and E. C. Hammond, Mortality effects of cigarette smoking among amosite asbestos factory workers, J. Natl. Cancer Inst., 65: 507–513 (1980).
I. J. Selikoff, E. C. Hammond, and H. Seidman, Mortality experience of insulation workers in the United States and Canada 1943–1976, Ann. N.Y. Acad. Sci., 330: 91–116 (1979).
J. C. Wagner, C. A. Sleggs, and P. Marchand, Diffuse pleural mesothelioma and asbestos exposure in North Western Cape Province; Br. J. Ind. Med., 17: 260–271 (1960).
K. H. Antman, R. H. Blum, J. S. Greenberger, G. Flowerdew, A. T. Skarin, and G. P. Canellos, Multimodality therapy for malignant mesothelioma based on a study of natural history, Amer. J. Med., 68: 356–362 (1980).
K. C. Kuo, C. W. Gehrke, R. A. McCune, T. P. Waalkes, and E. Borek, Rapid, quantitative, high-performance liquid column chromatography of Pseudouridine, J. Chromatogr., 145: 383–392 (1978).
C. W. Gehrke, K. C. Kuo, G. E. Davis, R. D. Suits, T. P. Waalkes, and E. Borek, Quantitative high performance liquid chromatography of nucleosides in biological materials, J. Chromatogr., 150: 455–476 (1978).
K. C. Kuo, T. F. Cole, C. W. Gehrke, T. P. Waalkes, and E. Borek, Dual-column, cation-exchange chromatographic method for 3-aminoisobutyric acid and β-alanine in biological samples, Clin. Chem., 24: 1373–1380 (1978).
A. Fischbein, 0. K. Sharma, I. J. Selikoff, and E. Borek, Urinary excretion of nucleosides in patients with malignant mesothelioma, Cancer Research, 43: 2971–2974 (1983).
W. J. Nicholson, G. Perkel, and I. J. Selikoff, Occupational exposure to asbestos: population at risk and projected mortality 1980–2030, Am. J. Ind. Mad., 3: 259–312 (1982).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Plenum Press, New York
About this chapter
Cite this chapter
Fischbein, A., Bekesi, J.G., Selikoff, I.J., Borek, E. (1984). The Use of Immunological and Molecular Biological Techniques in the Assessment of Occupational and Environmental Disease. In: de Serres, F.J., Pero, R.W. (eds) Individual Susceptibility to Genotoxic Agents in the Human Population. Environmental Science Research, vol 30. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2765-3_8
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2765-3_8
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9709-3
Online ISBN: 978-1-4613-2765-3
eBook Packages: Springer Book Archive